Marcella Occelli

Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo — Italy

Medicine · Health Sciences

20h-index1.3kcitations63works13.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(18), Cutaneous Melanoma Detection and Management(12), CAR-T cell therapy research(12), Melanoma and MAPK Pathways(11), Immunotherapy and Immune Responses(10)

Publications60 total

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation
Tumori Journal·2025
2751 Cemiplimab-Radiotherapy combination in cutaneous squamous cell carcinoma(cSCC) inoperable-locally advanced or metastatic: safety and efficacy profile.
Radiotherapy and Oncology·2025
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
European Journal of Cancer·2024· 41 citedOpen Access
2124P The impact of NUTRItional status at first medical oncology visit ON Clinical Outcomes: The NUTRIONCO study
Annals of Oncology·2023Open Access
Patients with cancer and hospital admissions: disease trajectory and strategic choices
BMJ Supportive & Palliative Care·2023· 5 cited
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study
Cancers·2023· 21 citedOpen Access
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
European Journal of Cancer·2023· 19 citedOpen Access
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma
Journal of Translational Medicine·2022· 65 citedOpen Access
Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience
Frontiers in Oncology·2021· 15 citedOpen Access
Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review
European Journal of Case Reports in Internal Medicine·2021· 8 citedOpen Access
Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study
ESMO Open·2021· 53 citedOpen Access
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
Cancers·2021· 29 citedOpen Access
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates
BMC Cancer·2021· 3 citedOpen Access
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates
2020Open Access
The surgical treatment of non metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates
2020Open Access
Real Life Clinical Management and Survival in Cutaneous Malignant Melanoma: the Italian Clinical National Melanoma Registry (CNMR) Experience
Preprints.org·2020· 2 citedOpen Access
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival
Frontiers in Oncology·2020· 23 citedOpen Access
1950P TRANSLATE: Activation of immune response in refractory patients to standard treatment
Annals of Oncology·2020
1107P Clinical outcomes to checkpoint inhibitors in NRAS mutated metastatic melanoma (MM) compared with wild type BRAF/NRAS: An Italian Melanoma Intergroup (IMI) study
Annals of Oncology·2020
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy
Tumori Journal·2020· 1 cited
page 1 of 3Next →

Frequent Co-authors

Marco Merlano(22), Ornella Garrone(21), Elena Fea(15), Ida Colantonio(13), Pietro Quaglino(12), Paola Queirolo(12), Gianmauro Numico(11), Cristina Granetto(11), Michele Guida(11), Paolo A. Ascierto(9), Jacopo Pigozzo(8), Gianna Di Costanzo(7), Vanna Chiarion‐Sileni(7), Sabino Strippoli(7), Barbara Merelli(7), Mario Mandalà(7), Vincenzo De Giorgi(7), Milena Gasco(6), Anna Maria Di Giacomo(6), Marco Tucci(6)